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Previous reports indicated a correlation between loss of plasmids and decreased infectivity of Borrelia
burgdorferi strain B31, suggesting that plasmids may encode proteins that are required for pathogenesis. In this
study, we expand on this correlation. Using the B. burgdorferi genomic sequence, we designed primers specific
for each plasmid, and by using PCR we catalogued 11 linear and 2 circular plasmids from 49 clonal isolates
of a mid-passage B. burgdorferi strain B31, initially derived from infected mouse skin, and 20 clones obtained
from mouse skin infected with a low-passage isolate of B. burgdorferi strain B31. Among the 69 clones analyzed,
nine distinct genotypes were identified relative to wild-type B. burgdorferi strain B31. Among the nine clonal
genotypes obtained, only the 9-kb circular plasmid (cp9), the 25-kb linear plasmid (lp25), and either the 28-kb
linear plasmid 1 or 4 (lp28-1 and lp28-4, respectively) were missing, in different combinations. We compared
the infectivity of the wild-type strain, containing all known B. burgdorferi plasmids, with those of single mutants
lacking either lp28-1, lp28-4, or lp25 and a double mutant missing both cp9 and lp28-1. The infectivity data
indicated that B. burgdorferi strain B31 cells lacking lp28-4 were modestly attenuated in all tissues analyzed,
whereas samples missing lp25 were completely attenuated in all tissues, even at the highest inoculum tested.
Isolates without lp28-1 infected the joint tissue yet were not able to infect other tissues as effectively. In
addition, we have observed a selection in vivo in the skin, bladder, and joint for cells containing lp25 and in
the skin and bladder for cells containing lp28-1, indicating that lp25 and lp28-1 encode proteins required for
colonization and short-term maintenance in these mammalian tissues. In contrast, there was no selection in
the joint for cells containing lp28-1, suggesting that genes on lp28-1 are not required for colonization of B.
burgdorferi within the joint. These observations imply that the dynamic nature of the B. burgdorferi genome may
provide the genetic heterogeneity necessary for survival in the diverse milieus that this pathogen occupies in
nature and may contribute to tropism in certain mammalian host tissues.
Lyme borreliosis, or Lyme disease, is a multisystemic inflam-
matory disorder transmitted by the bites of ticks infected with
the spirochetal bacterium Borrelia burgdorferi sensu lato (13,
25). Over the past 15 years, Lyme disease has become the most
frequent arthropod-borne disease in the United States and has
been identified in a latitudinal strip in the Northern hemi-
sphere including Europe, Eurasia, and Asia (2, 4, 5, 29). De-
termination of the genomic sequence of B. burgdorferi strain
B31 by The Institute of Genomic Research (TIGR), along with
several other investigators, in 1997 revealed that this spiro-
chete contained a unique genomic organization consisting of a
linear chromosome of 910 kb in size and several plasmids
(reference 8 and the TIGR website [http://www.tigr.org/tdb/
mdb/bbdb/bbdb.html]). Complete annotation of the genome
sequence indicated that B. burgdorferi contained 21 plasmids,
i.e., 12 linear plasmids ranging in size from 5 to 56 kb (desig-
nated by lp followed by their size in kilobase pairs) and 9
circular plasmids with sizes between 9 and 32 kb (designated by
cp followed by the size in kilobase pairs) (5; TIGR website).
Previous studies with other pathogens, including Shigella flex-
neri, Yersinia spp., and Salmonella enterica serovar Typhimu-
rium (7, 15), indicated that virulence determinants were often
plasmid encoded and that, in some instances, loss of the viru-
lence-associated plasmid resulted in either a decrease or an
abrogation of pathogenicity. The hypothesis that B. burgdorferi
plasmids carry infection-associated genes is supported by the
fact that prolonged serial in vitro cultivation of infectious non-
clonal isolates changes the plasmid and protein profiles of the
organism and results in the loss of infectivity (9, 21, 22, 30).
Reports published before the genome project was completed
indicated a reduction in infectivity when several plasmids in the
24- to 28-kb range, as well as a 9-kb circular plasmid designated
cp9, were lost (30). Since then, a 28-kb linear plasmid, desig-
nated lp28-1, has been linked to a reduced-infectivity pheno-
type (32).
The purpose of this study was to identify plasmids, including
lp28-1, that correlate with the infectious phenotype and to
determine whether tissue tropism is related to plasmid content
in B. burgdorferi strain B31. With the advent of the B. burgdor-
feri strain B31 genome sequence information, we designed
PCR primers specific to 11 linear and 2 circular plasmids and,
in conjunction with PCR, determined the plasmid content of
69 separate clones of B. burgdorferi strain B31. Of the 69 clones
tested, 20 were from mouse skin infected with a low-passage
isolate and 49 were from a mid-passage isolate initially ob-
tained from an infected mouse. We then assessed the require-
ment for specific plasmids in the pathogenesis of B. burgdorferi
by testing appropriate clones in the mouse model of Lyme
borreliosis and quantitatively assessing the infectivity deficits of
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these mutants relative to wild-type B. burgdorferi strain B31.
Furthermore, we determined the plasmid content of clones
obtained from our infectivity studies to determine whether
genotypic changes occurred in vivo. The results presented in
this report challenge the paradigm of clonality as it applies to
B. burgdorferi, as cells containing different plasmid combina-
tions were obtained from an individual colony, perhaps due to
deficits in plasmid partitioning upon replication. Finally, the
observation that B. burgdorferi clones are genetically variable
when isolated from different infected animal tissues suggests
that genetic mosaics of B. burgdorferi are tolerated in vivo and
result in variants with differential infectivity phenotypes and
tissue-tropic properties.
MATERIALS AND METHODS
Bacterial strains. B. burgdorferi sensu stricto strain B31 (ATCC 35210) was
used exclusively in this study. This isolate of strain B31 was originally isolated
from ticks on Shelter Island, New York, and appears, based on Southern blot-
ting, PCR, and nucleotide sequencing (reference 23 and data not shown), to be
identical to the TIGR isolate previously sequenced (TIGR website). The deriv-
atives of strain B31 obtained in this study and their relevant genotypes are
indicated in Table 1. All B. burgdorferi cultures were grown in 1% CO2 at 32°C
either in BSK-II liquid medium lacking gelatin (3) or on BSK-II agarose plates
as described previously (20), both supplemented with 6% normal rabbit serum
(Pel-Freez Biologicals, Rogers, Ark.). A polyclonal B. burgdorferi strain B31
passage 2 isolate was used to infect mice intradermally at an inoculum of 103
cells, and skin samples were cultured at 4 weeks postinfection in BSK-II medium.
B. burgdorferi cells were enumerated from these cultures using dark-field micros-
copy, serially diluted in BSK-II medium, and plated onto BSK-II agarose in
overlays as previously described (14). Individual colonies were obtained and
cultured in BSK-II medium to mid- to late-log phase (approximately 108 B.
burgdorferi cells per ml), and their corresponding plasmid profiles were deter-
mined using PCR as outlined below. In addition, a B. burgdorferi strain B31
isolate that had been passaged 48 times in vitro (designated P48) was plated on
BSK-II agarose plates, individual colonies were picked, and template DNA
prepared and subjected to PCR as outlined below. Clones obtained from the P48
infectivity analysis (see “ID50 determinations” below) were isolated from in-
fected mouse tissues by plating samples diluted from BSK-II liquid cultures in
BSK-II agarose overlays as previously described (3, 14, 20).
PCR analysis. The complete sequences of all of the open reading frames in
each plasmid were retrieved from the B. burgdorferi strain B31 genome database
(TIGR website) and saved as MacVector version 6.5 files (Oxford Molecular
Group, Inc., Campbell, Calif.). Primer sets, specific for an entire gene coding
sequence, were designed for all of the plasmids with the exception of the 32-kb
circular plasmids (cp32), due to their inherent similarities, and linear plasmid 21
(lp21), because of its similarity to linear plasmid 5 (lp5) (5, 28). The primers used
in this study are listed in Table 2. Primers specific for lp36 (BBK19F and
BBK19R) were predicted to yield a 610-bp fragment (Table 2). However, we
found that the BBK19F oligonucleotide primer alone was capable of amplifying
a 316-bp PCR product. BBK19F hybridizes to both strands in the proper orien-
tation, yielding this PCR amplimer, even though the annealing site in the reverse
TABLE 1. B. burgdorferi strain B31 genotypic variants
used in this study
B31
variant(s) Description
Source or
reference
MSK5 Clone obtained from the skin of a mouse
infected with low passage B. burgdorferi B31
and determined to have all of the known
plasmids
This study
MSK7 Clone obtained from the skin of a mouse
infected with low-passage B. burgdorferi B31
and determined to be lp28-42
This study
MSK10 Clone obtained from the skin of a mouse
infected with low-passage B. burgdorferi B31
and determined to be lp28-12
This study
P48 B. burgdorferi B31 isolate originally obtained
from a mouse infected with low-passage
B. burgdorferi B31 and serially passaged
in vitro 48 times
6
ML28 Clone isolated from nonclonal P48 sample
and determined to be cp92 and lp28-12
This study
ML23 Clone isolated from nonclonal P48 sample
and determined to be lp252
This study
MJ1 to -20 Clones from tibiotarsal joint tissue of mice
infected with clone ML28 passage 2
This study
OMB1 to -20 Clones isolated from bladder tissue of mice
infected with nonclonal P48 sample
This study
OMS1 to -20 Clones isolated from skin tissue of mice
infected with nonclonal P48 sample
This study
OMJ1 to -99 Clones isolated from tibiotarsal joint tissue of
mice infected with nonclonal P48 sample
This study
TABLE 2. Oligonucleotides used in this study
Plasmid Genomedesignation Sequence (59 to 39)
Predicted
fragment
size (bp)
cp9 BBC10F GAACTATTTATAATAAAAAGGAGAGC 459BBC10R ATCTTCTTCAAGATATTTTATTATAC
BBC07F GATGAAAATCTTTCACAAAAG 291BBC07R AACAATAATAGAGATAAAGGG
cp26 BBB19F AATAATTCAGGGAAAGATGGG 573BBB19R AGGTTTTTTTGGACTTTCTGCC
lp5 BBTF CTTGCTTTAAGCCCTATTTCAC 645BBTR GCACACTACCCATTTTTGAATC
lp17 BBD10F CAAACTTATCAAATAGCTTATC 519BBD10R ACTGCCACCAAGTAATTTAAC
lp25 BBE16F ATGGGTAAAATATTATTTTTTGGG 618BBE16R AAGATTGTATTTTGGCAAAAAATTTTC
lp28-1 BBF20F ATGAACAAAAAATTTTCTATTTC 291BBF20R GTTGCTTTTGCAATATGAATAGG
BBFF CGCTGGACAGTTTATATTGGGG 1,723BBFR GTTGATAATGCTAATGCTGGGGAC
lp28-2 BBG02F TCCCTAGTTCTAGTATCTACTAGACCG 810BBG02R TTTTTTTTGTATGCCAATTGTATAATG
lp28-3 BBH06F GATGTTAGTAGATTAAATCAG 651BBH06R TAATAAAGTTTGCTTAATAGC
lp28-4 BBI16F CAGGCCGGATTTTAATATCGA 1,300BBI16R GTTTATATTTTGACACTATAAG
BBI16(II)F GCAGGCCGGATTTTAATATCGATC 732BBI16(II)R GCTCATTAGATAGCGTATTTTTTAG
lp36 BBK19F AAGTTTATGTTTATTATTGC 316 (610)aBBK19R ATTGTTAGGTTTTTCTTTTCC
lp38 BBJ34F AAATTCTATGGAAGTGATG 1,010BBJ34R TTTCTATTTATTTTTAGGC
lp54 BBA16F GCACAAAAAGGTGCTGAG 840BBA16R TTTTAAAGCGTTTTTAAGC
lp56 BBQ56F AAGATTGATGCAACTGGTAAAG 975BBQ56R CTGACTGTAACTGATGTATCC
a BBK19F anneals to both strands, yielding a 316-bp amplimer; see text for
details.
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orientation contains five mismatches. In all samples tested, the 316-bp band was
observed (see Fig. 1 and 2). No other oligonucleotide primer sets yielded anom-
alous PCR products.
Total DNA was extracted from a liquid culture of each isolate once it had
reached mid-log phase. Template was obtained by pelleting B. burgdorferi at
4,000 3 g for 15 min, washing the bacteria in an equal volume of phosphate-
buffered saline (PBS) (pH 7.4), repelleting the cells as before, and resuspending
the resulting pellet in water such that the final concentration was 5 3 106 B.
burgdorferi equivalents per ml. The samples were then boiled for 5 min, the
insoluble material was pelleted, and the supernatant containing the DNA was
removed. One microliter of the resulting supernatant was used as a DNA tem-
plate (i.e., 5 3 106 B. burgdorferi equivalents), and each primer was used at a
concentration of 0.2 mM in a 20-ml PCR mixture containing PCR Supermix
(GIBCO-BRL, Gaithersburg, Md.) as the source of Mg21, deoxynucleotides, and
Taq polymerase. The PCR parameters used were as follows: a denaturation step
at 94°C for 1 min; 35 cycles of denaturation at 94°C for 1 min, annealing at 45°C
for 1 min, and extension at 72°C for 2 min; and a final extension step at 72°C for
6 min. PCR products were resolved by agarose gel electrophoresis and visualized
by ethidium bromide staining.
Southern blots. Southern blotting was conducted essentially as described pre-
viously (23) with the following modifications. The template for the random
priming reaction was either a PCR product or purified plasmid DNA. Prepara-
tion of probes using plasmid DNA was done as previously outlined (23). When
a PCR amplimer was used, roughly 500 ng of the PCR product was resolved on
an agarose gel and the band of the appropriate size was excised. The DNA was
removed and incubated with Tris-HCl buffer-saturated phenol. The sample was
flash frozen and separated into phases by centrifugation. The upper aqueous
phase was extracted with 2:1 phenol-chloroform and separated by centrifugation,
and the resulting aqueous phase was extracted again with chloroform. The DNA
was then precipitated, and the final washed pellet was resuspended in 20 ml of
sterile water. A 19-ml portion of the final sample was used as a template with
either the Gene Images system (Amersham Pharmacia Biotech, Piscataway, N.J.)
or the Renaissance system (NEN Life Science Products Inc., Boston, Mass.),
which resulted in the incorporation of fluoresceinated dUTP into a randomly
primed probe. The DNA samples to be tested were isolated from approximately
2 3 1010 B. burgdorferi cells using Qiagen (Chatsworth, Calif.) tip 100 or tip 500
columns. Subsequently, the DNA was digested and either transferred or dot
blotted onto a nylon membrane (Hybond-N; Boehringer Mannheim Inc., Indi-
anapolis, Ind.) and subjected to Southern blotting as previously described (23).
Probes that hybridized to immobilized DNA were detected by incubating the
blots with antifluorescein antibodies conjugated to horseradish peroxidase
(HRP) and were exposed to Kodak XAR-5 X-ray film following incubation with
the appropriate chemiluminescent substrate (enhanced chemiluminescence
[ECL] developing reagents [Amersham Pharmacia Biotech]).
ID50 determinations. Three 8-week-old C3H/HeN female mice (Charles River
Laboratories, Wilmington, Mass.) were separately infected by intradermal inoc-
ulation with 10-fold serial dilutions of the different B. burgdorferi B31 mutant
isolates to be tested, at levels of 10, 102, 103, 104, and 105 B. burgdorferi strain B31
variants. Two weeks later, mice were sacrificed and the spleen, tibiotarsal joint,
lymph node, heart, bladder, and abdominal skin were removed aseptically. Tis-
sues were processed using sterile pestles and placed in liquid BSK-II medium.
Cultures were passaged blindly 5 days later into fresh BSK-II medium to mini-
mize toxicity associated with host tissue. Tubes were examined for borrelial
growth every week thereafter using dark-field microscopy, and the 50% infective
dose (ID50) was calculated using the method of Reed and Muench (16) as
outlined by Norris et al. (14).
PAGE. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) was conducted as described previously (24). After SDS-PAGE, the
resulting gel was stained with Coomassie brilliant blue or transferred to an
Immobilon-P polyvinyl difluoride membrane and immunoblotted as described
below.
Immunoblot analysis. Immunoblotting was conducted as described previously
(23) using the following antisera as primary antibodies: normal mouse serum,
pooled sera from mice infected for 6 weeks with 103 B. burgdorferi strain B31
derivative MSK5 cells (contains all known borrelial plasmids; see above and
Results for details), serum from a patient with late Lyme disease manifestations
(kindly provided by Allen Steere, Tufts University, Boston, Mass.), adsorbed
serum from infection-immune rabbits (6), or antiserum against VlsE (generously
provided by Steven Norris, University of Texas Health Science Center, Houston).
Following transfer, the polyvinylidene difluoride membrane was blocked in 10%
powdered milk in PBS (pH 7.4)–0.2% Tween 20 (PBST) for 1 h at room
temperature. The blot was then incubated separately with each primary antibody
(indicated above) diluted 1:1,000 (or, for the anti-VlsE serum, diluted 1:5,000) in
10% powdered milk in PBST for 1 h and subsequently washed in PBST. After the
wash step, each blot was incubated with a 1:1,000 dilution of protein A conju-
gated to HRP (Amersham Corp., Arlington Heights, Ill.). The blots were then
washed with PBST to eliminate unbound protein A-HRP, developed using the
ECL system (Amersham Corp.), and exposed to Kodak XAR-5 film for times
ranging from 1 to 30 min.
Statistical analysis. Infectivity data were analyzed using a nonparametric
chi-square test. Significant differences were accepted when the P value was
,0.05.
RESULTS
Design of PCR primers. Several investigators have previ-
ously demonstrated that B. burgdorferi loses plasmid DNA in
response to in vitro passage and that the loss of plasmids
correlates with a decrease in infectivity, implying that genetic
loci within these plasmids encode virulence determinants (14,
21, 22, 30; J. E. Purser and S. J. Norris, Abstr. 100th Gen.
Meet. Am. Soc. Microbiol., abstr. D-214, p. 275, 2000). The
large number of plasmid species (12 linear and 9 circular) have
made it difficult to definitively determine which of the plasmids
were missing from B. burgdorferi isolates, due to their low copy
number (10) and because several of these species are similar in
size (for example, four linear plasmids of approximately 28 kb
designated lp28-1, lp28-2, lp28-3, and lp28-4 [8]). Also, the
possibility that circular plasmids comigrate with linear plas-
mids contributed to the inability to accurately resolve these
different species. To circumvent these issues, we used the avail-
able genomic sequence of Borrelia burgdorferi strain B31
(TIGR website) to design specific PCR primers for 11 linear
and 2 circular plasmids. We excluded the seven 32-kb circular
plasmids (cp32-1, -3, -4, -6, -7, -8, and -9 [5; TIGR website])
from consideration since they are nearly identical at the nu-
cleotide level, with the notable exceptions of the ospEF/elp
(also called erp) loci, the mlp genes, and the bdr paralogues (17,
18, 28, 31, 33). More importantly, no correlation in infectivity
was seen in strains containing various combinations of the cp32
plasmids, both in our laboratory (data not shown) and by
others (J. V. McDowell, S. Y. Sung, and R. T. Marconi, un-
published data). The 21-kb linear plasmid (lp21) was also elim-
inated, since it is nearly identical to the 5-kb linear plasmid
(lp5) with the exception of a nonencoding repetitive domain
that contributes approximately 12.8 kb of the lp21 sequence
(the TIGR sequence indicated that lp21 was 18,753 nucleo-
tides total [5; TIGR website]). For the remaining plasmids, a
single gene was chosen and analyzed using the MacVector 6.5
software package to predict PCR primers that would generate
amplicons diagnostic for each plasmid. Due to the frequency of
paralogous genes within the B. burgdorferi genome (5, 8; TIGR
website), we identified genes that were unique to each plasmid
to prevent the coamplification of multiple PCR products un-
linked to the gene or plasmid of interest. Primers were chosen
for a given plasmid-encoded gene and tested against a com-
posite file of the B. burgdorferi plasmid DNA to ensure that the
primer pair was specific (data not shown). Oligonucleotide
primers that had significant homology with other paralogous
sequences (i.e., contained three or four mismatches) were
eliminated from consideration. Oligonucleotide primer pair
sequences, the genes they amplify, and the expected sizes of
the DNA fragments they amplify are indicated in Table 2.
Stability of clonal isolates. To begin analyzing the genotypic
differences and their potential linkage to infectivity in B. burg-
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dorferi strain B31, we infected C3H/HeN mice intradermally
and isolated 20 independent colonies from skin samples culti-
vated on BSK-II agarose plates. DNA from these 20 clones was
subjected to PCR analysis, and two mutants were obtained,
one missing lp28-1 (designated MSK10) and one lacking lp28-4
(designated MSK7) (Fig. 1). The remaining 18 isolates con-
tained all plasmids tested, and one of these samples, termed
MSK5, has been designated our wild-type strain (Fig. 1). We
then subjected MSK5, MSK7, and MSK10 to numerous in vitro
passages in an attempt to isolate mutant strains lacking differ-
ent plasmids, since this approach has been used by several
investigators to generate genetically distinct populations of B.
burgdorferi (14, 21, 22). Using PCR to evaluate these potential
changes, we did not observe the loss of any additional plasmids
from MSK5, MSK7, or MSK10 after as many as 27 in vitro
passages (data not shown), indicating that B. burgdorferi is
genetically stable when cultivated for numerous generations
within our laboratory.
Isolation of clones from mid-passage B. burgdorferi strain
B31. Our inability to isolate genetically diverse populations of
B. burgdorferi strain B31 isolate MSK5, MSK7, or MSK10 after
extensive in vitro passages prompted us to utilize a different
methodology to obtain genetically diverse B. burgdorferi clones.
We plated and isolated colonies from B. burgdorferi strain B31
P48, which had been passaged 48 times in vitro; this strain was
less virulent in the rabbit model of Lyme borreliosis and was
incapable of completely protecting against challenge with a
low-passage, infectious isolate (6). This phenotype implied that
P48 was attenuated due to genetic differences relative to wild-
type, low-passage B. burgdorferi strain B31. In support of this
contention, PCR analysis of the polyclonal P48 sample indi-
cated that the cp9 plasmid was not present (Fig. 2). Given that
cp9 has been associated with infectious isolates, we suspected
that this genetic difference might, in part, explain the pheno-
type associated with P48. We subsequently plated P48 into
agarose overlays and incubated the resulting samples until
colonies were apparent (approximately 10 to 14 days). After
this time, 49 individually isolated colonies were picked and
cultured in BSK-II liquid medium, and the DNA from each
sample was prepared for PCR as described in Materials and
Methods. PCR-amplified DNA from the 11 linear plasmids
and 2 circular plasmids from all 49 samples was resolved on
agarose gels, and eight genotypic groups of B. burgdorferi strain
B31 P48 were identified (Table 3). Table 3 shows that of the 13
plasmids analyzed, only cp9, lp25, lp28-1, or lp28-4 were miss-
ing from the clones characterized, in various combinations and
at different frequencies. Furthermore, cp9 was detected by
PCR in 4.1% of the clones, indicating that the initial plasmid
profile of P48 yielded a false negative for cp9 compared with
the overall genetic complexity of the polyclonal population. All
FIG. 1. Plasmid profiles of B. burgdorferi strain B31 clones MSK5,
ML28, ML23, ML28, and MSK10. PCR analysis was performed as
detailed in Materials and Methods with oligonucleotide primers listed
in Table 2. PCR products were resolved by electrophoresis on a 1.5%
agarose gel. Molecular size markers (in base pairs) are indicated on the
left. The asterisk in the MSK7 panel indicates the location of a putative
primer dimer observed with the lp28-4 oligonucleotide primers.
FIG. 2. Plasmid profile of the polyclonal B. burgdorferi strain B31
passage 48 (P48) sample. PCR analysis was performed as detailed in
Materials and Methods using the primers shown in Table 2. PCR
products were resolved by electrophoresis in a 1.5% agarose gel. Mo-
lecular size markers (in base pairs) are indicated on the left.
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other plasmids tested (i.e., cp26, lp5, lp17, lp28-2, lp28-3, lp36,
lp38, lp54, and lp56) were present in every sample tested (data
not shown). The most common isolate observed lacked cp9,
lp25, and lp28-4, followed by clones that were missing all four
plasmids (Table 3). Our data indicate that of the four plasmid
species whose presence was variable, lp28-1 was most com-
monly observed in the different clonal isolates (69.4%), fol-
lowed distantly by lp25 (10.2%), lp28-4 (10.2%), and cp9
(4.1%). In some instances cp9, lp25, lp28-1, and lp28-4 signals
appeared as faint bands in various clones following PCR rel-
ative to wild-type MSK5, to which the bands were normalized
following agarose gel electrophoresis (as indicated in Table 3).
This result suggested that loss of plasmids might be occurring
over time, thereby converting a genetically identical clone into
a mixed collection of genetically variable cells. From the clones
characterized, we selected four mutants missing either cp9,
lp25, lp28-1, or lp28-4 to characterize further.
Genetic characterization of mutant clones. Several of the B.
burgdorferi strain B31 clones that we identified were lacking a
single plasmid based on PCR analysis, including a putative
cp92 mutant designated ML28 and an lp252 mutant desig-
nated ML23 (Fig. 1). Since we already had mutants lacking
either lp28-1 or lp28-4 alone (MSK10 and MSK7, respectively
[Fig. 1]), we next wanted to determine the infectivity deficit
associated with each of these clones relative to the wild-type
strain, MSK5. C3H/HeN mice were infected with 10-fold serial
dilutions of all five strains, i.e., MSK5 (wild-type strain), ML28
(cp92), ML23 (lp252), MSK10 (lp28-12), and MSK7 (lp28-
42), and various tissues from each infected mouse were re-
moved aseptically at 2 weeks postinfection. The tissues were
cultured in BSK-II medium and scored for growth at each
dilution. The results are summarized in Table 4 and indicate
that the infectious dose calculated for the wild-type strain,
MSK5, was identical to that reported previously for B. burg-
dorferi strain Sh-2-82 by Norris et al. (14). Furthermore, we
determined that the strain lacking lp28-4 alone, MSK7, showed
a slight but detectable infectivity deficit relative to wild-type
MSK5, as seen by a 1-log-unit increase in the ID50 for all
tissues tested except the heart. In contrast, MSK10, which lacks
lp28-1, was significantly attenuated in its ability to colonize the
spleen and lymph node and showed low-level infectivity in the
heart, bladder, and skin, yet it demonstrated significant infec-
tivity in joint tissue, albeit less than wild-type MSK5 (ID50 of
3.2 3 103 in the joint for MSK10-infected mice versus an ID50
of 1.8 3 102 for the joints of mice infected with MSK5 [Table
4]). Similarly, strain ML28 was attenuated in C3H/HeN mice in
all tissues except the tibiotarsal joint. However, the most dra-
matic effect was seen in strain ML23, lacking lp25, which was
completely noninfectious for all challenge inocula tested, sug-
gesting that lp25 encodes virulence determinants required for
normal colonization and/or dissemination in C3H/HeN mice.
The similar infectivity deficits and tissue-tropic defects ob-
served for MSK10 and ML28 prompted us to reevaluate the
genotypic profiles of the mutant strains we had isolated. Be-
cause we had used PCR initially to assess the plasmid content
of our clones, it is conceivable that we had identified false
positives due to the inherent sensitivity of this method. To
assess this, we used DNA purified from each strain and sub-
jected these samples to either conventional Southern blot or
dot blot analyses using PCR-amplified probes specific for cp9,
lp25, lp28-1, lp28-4, and, as a positive control for all strains
tested, lp54 (see Table 2 for plasmid-specific probes used).
Using this approach, we determined that ML28, a clone miss-
ing cp9, was also lp28-12 (Fig. 3). All other clones contained
the plasmid DNA determined previously (Fig. 1). Our results
indicate that the threshold for detection in our dot blot anal-
yses is between 104 and 105 B. burgdorferi cells (data not
shown) and is independent of the probe used. In contrast, our
PCR sensitivity data demonstrate that a positive PCR signal
requires DNA derived from only 50 to 50,000 B. burgdorferi
cells, depending on the primer set used (data not shown), and
in some instances resulted in the erroneous characterization of
the plasmid content of the clones tested (see, e.g., lp28-1 lane
for ML28 in Fig. 1).
ML28 and MSK10 have similar infectivity phenotypes, im-
plying that the correlation between cp9 and any marked effect
related to infectivity is not substantial. Instead, our results were
only able to indicate that lp25 and lp28-1 are important for
infectivity in the C3H/HeN mouse. The other plasmids that
were missing from our clones, cp9 and lp28-4, have only subtle
effects on the establishment and dissemination of B. burgdorferi
strain B31. Our results do not exclude the possibility that other
plasmids are important for pathogenesis, but, in the absence of
such additional mutants in this study, it is impossible to eval-
uate these phenotypes (see Discussion). Taken together, our
results indicate that lp25, either directly or indirectly, encodes
determinants that drastically alter the infectivity phenotype of
B. burgdorferi strain B31, presumably due to a colonization
defect. Also, strains lacking lp28-1 show a dramatic infectivity
deficit as well, being capable of effectively colonizing only the
joint, although other tissues are also infected at low levels (see
MSK10 data in Table 4). This phenotype is accentuated in
ML28, which lacks both lp28-1 and cp9, suggesting that the
tropism for additional tissue compared to what is observed in
MSK10, albeit subtle, is due to cp9-derived sequences.
Characterization of protein and antigenic content. We next
wanted to determine whether differences at the genetic level
would yield notable differences in the protein or antigen pro-
duced by these clones. The loss of a given plasmid could result
in the loss of proteins encoded by that particular plasmid or
could affect the global expression of genes at distal sites. To
determine whether this occurred, we subjected each isolate to
TABLE 3. Genotypic compositions of ML clones derived
from a nonclonal P48 isolate
Plasmid(s) absent No. of clones (%)(n 5 49)
cp9, lp25, lp28-1, lp28-4....................................................... 13a (26.5)
cp9, lp25, lp28-4.................................................................... 26b (53.1)
cp9, lp28-1, lp28-4 ................................................................ 1 (2.0)
cp9, lp25................................................................................. 4c (8.2)
cp9, lp28-4 ............................................................................. 2 (4.1)
cp9, lp28-1 ............................................................................. 1d (2.0)
lp25, lp28-4 ............................................................................ 1 (2.0)
lp28-4...................................................................................... 1 (2.0)
a Two clones had a low PCR signal for lp25, five clones had a low PCR signal
for lp28-1, and one clone had a low PCR signal for lp28-4.
b Three clones had a low PCR signal for lp25, and two clones had a low PCR
signal for cp9.
c Two clones had a low PCR signal for cp9.
d The clone had a low PCR signal for lp28-1.
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SDS-PAGE and ECL immunoblotting using serum from either
infected mice, rabbits, or humans. Coomassie blue-stained gels
showed no overt differences (data not shown), and no change
was seen in the antigenic profiles, with the notable and ex-
pected exception of the antigenic variant VlsE (32), which was
missing from the lp28-12 strains MSK10 and ML28 (data not
shown). In addition, a single 24-kDa antigen was missing from
MSK7 in blots probed with sera from infected mice, implying
that the expression of this antigen is directly or indirectly
related to the presence of lp28-4 (data not shown).
Genotype of B. burgdorferi strain B31 variant ML28. Initially
our PCR analysis defined ML28 as a cp9 mutant. However,
after further characterization (Table 4 and Fig. 3), ML28 was
missing additional plasmids. Furthermore, its infectivity pat-
tern was similar to that observed for MSK10 (lp28-12). If a
given plasmid is missing from the majority of cells in a culture
derived from a clonal isolate yet is present at levels sufficient to
yield a positive PCR signal, then one would expect that upon
infection and isolation from the infected host, the plasmid
profile would most likely reflect the genotypic profile of the
challenge inoculum. To address this possibility, we took joint
tissue from mice infected with B. burgdorferi strain B31 isolate
ML28, plated the sample to isolate individual colonies, and
conducted PCR on 20 separate clones designated MJ1 through
MJ20 (Table 1). Our results indicated that 12 of these clones
were missing cp9, lp28-1, and lp28-4, while 5 lacked cp9 and
lp28-1 (data not shown). The remaining three clones were
either lp28-12 (two total) or a double mutant lacking both
lp28-1 and lp28-4 (data not shown). Seven of the 20 ML28
clones from infected joints were subjected to PCR with all of
the primer sets (Table 2), and, as before, no additional plas-
FIG. 3. Dot blot analysis of B. burgdorferi strain B31 clones. Fifty
nanograms of total plasmid DNA from each clone was blotted onto a
nylon membrane and hybridized with probes specific to the plasmids
indicated above the lanes. The clones tested are listed vertically on the
left (see Table 1 for details). The plasmid tested and the probe from
each plasmid are specified as follows (TIGR designations are used):
cp9, region including bbc10 (rev paralogue); lp25, bbe16; lp28-1, a 1.7-
kb region including bbf30, bbf31, and part of the bbf32 cassette region
described previously (32); lp28-4, bbi16 (vraA); and lp54, bba16 (ospB).
TABLE 4. ID50 determination for B. burgdorferi strain B31 clones
Isolate and
inoculum
No. of cultures positive/total no. No. of mice
positive/total
no. of mice
Calculated ID50
Spleen Joint Heart Bladder Skin Lymphnode
All
sites Spleen Joint Heart Bladder Skin
Lymph
node
MSK5a 1.8 3 102 1.8 3 102 1.8 3 102 1.8 3 102 1.8 3 102 1.8 3 102
105 3/3 3/3 3/3 3/3 3/3 3/3 18/18 3/3
104 3/3 3/3 3/3 3/3 3/3 3/3 18/18 3/3
103 3/3 3/3 3/3 3/3 3/3 3/3 18/18 3/3
102 1/3 1/3 1/3 1/3 1/3 1/3 6/18 1/3
101 0/3 0/3 0/3 0/3 0/3 0/3 0/18 0/3
MSK7b 1.9 3 103 3.2 3 103 5.6 3 102 1.9 3 103 1.9 3 103 1.9 3 103
105 3/3 3/3 3/3 3/3 3/3 3/3 18/18 3/3
104 3/3 2/3 3/3 3/3 3/3 3/3 18/18 3/3
103 1/3 1/3 2/3 1/3 1/3 1/3 7/18 2/3
102 0/3 0/3 0/3 0/3 0/3 0/3 0/18 0/3
101 0/3 0/3 0/3 0/3 0/3 0/3 0/18 0/3
MSK10b .105 104 3.4 3 104 105 105 .105
105 0/3 1/3 0/3 0/3 0/3 0/3 1/18 1/3
104 0/3 3/3 0/3 1/3 1/3 0/3 5/18 3/3
103 0/3 1/3 2/3 0/3 0/3 0/3 3/18 2/3
102 0/3 0/3 0/3 0/3 0/3 0/3 0/18 0/3
101 0/3 0/3 0/3 0/3 0/3 0/3 0/18 0/3
ML28c .105 3.2 3 103 .105 .105 .105 .105
105 0/3 3/3 0/3 0/3 0/3 0/3 3/18 3/3
104 0/3 1/3 0/3 0/3 0/3 0/3 1/18 1/3
103 0/3 2/3 0/3 0/3 0/3 0/3 2/18 2/3
102 0/3 0/3 0/3 0/3 0/3 0/3 0/18 0/3
101 0/3 0/3 0/3 0/3 0/3 0/3 0/18 0/3
ML23c .105 .105 .105 .105 .105 .105
105 0/3 0/3 0/3 0/3 0/3 0/3 0/18 0/3
104 0/3 0/3 0/3 0/3 0/3 0/3 0/18 0/3
103 0/3 0/3 0/3 0/3 0/3 0/3 0/18 0/3
102 0/3 0/3 0/3 0/3 0/3 0/3 0/18 0/3
101 0/3 0/3 0/3 0/3 0/3 0/3 0/18 0/3
a Wild type (refers to a clone not derived from nonclonal P48 that has been determined to have all of the known plasmids).
b Both of these clones were isolated from the skin from a mouse infected with low-passage B. burgdorferi strain B31.
c Both of these clones were derived from nonclonal P48.
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mids were missing from these isolates (data not shown); there-
fore, none of the remaining 13 clones were subjected to addi-
tional PCR with the remaining primer sets. These results
confirmed the data obtained from our dot blot analyses (i.e.,
that ML28 did not have lp28-1 or cp9 [Fig. 3]) and are consis-
tent with those reported by Purser and Norris (Abstr. 100th
Gen. Meet. Am. Soc. Microbiol.) for clones of B. burgdorferi
strain B31 that do not have lp28-1 in terms of their infectivity
deficit. In light of the minimal correlation observed for cp9
(compare MSK10 and ML28 [Table 4] and the modest effect
seen for lp28-4 (MSK7 [Table 4]), the infectivity defect and
retention of tropism for joint tissue observed for ML28 ap-
pears to be mediated either directly or indirectly by lp28-1.
In vivo selection of polyclonal B. burgdorferi strain B31 P48.
We established that our polyclonal P48 isolate was composed
of numerous genotypic variants (Table 3) and determined the
infectivity and tissue-tropic defect associated with some of
these clones as indicated above. We next wanted to elucidate
whether the mouse could be used to select specifically for
variants that were of the high-infectivity phenotype. This type
of positive selection would both validate our previous results
and corroborate which of the plasmids were required for col-
onization in C3H/HeN mice. C3H/HeN mice were infected
with serial dilutions of the polyclonal B. burgdorferi strain B31
P48 isolate, and an ID50 was determined. The results indicated
that the P48 isolate had the same infectivity phenotype as the
low-passage, wild-type MSK5 strain for all tissues tested except
the skin, suggesting that a selection for the infectious, highly
virulent B. burgdorferi cells had occurred within these mice
(Table 5).
To prove that the infectious forms of strain B31 P48 were
present within these tissue samples, we plated out tissue from
skin, bladder, and joint and screened individual colonies for
their plasmid content via PCR amplification. One would pre-
dict that if the mouse (i.e., in vivo) positively selects for infec-
tious isolates of B. burgdorferi from a mixed polyclonal pool,
then the clones obtained from infected tissues should contain
plasmids that are required for maintenance of the spirochetes
within these tissues. The results are summarized in Table 6 and
indicate that all 139 clones contained lp25, even though only
10% of the polyclonal population of P48 contained this plas-
mid (Tables 3 and 6). The selection observed for lp25 in the
mouse relative to in vitro cultivation was highly significant, with
a probability (P) value of less than 0.001 (Table 6). In contrast
to lp25, the data for cp9 and lp28-4 show that there was no
dramatic selection for cells carrying these plasmids, particu-
larly for cp9 in that only 1 of the 139 clones tested contained
this plasmid (see Table 6 for statistical significance). Interest-
ingly, lp28-1 appeared to be present in vivo overall at a fre-
quency commensurate with the value calculated for in vitro-
cultivated cells (80.6% in vivo relative to 69.4% in vitro [Table
6]). However, when the tissues are compared against one an-
other, a statistically significant selection for lp28-1 is evident
within the bladder tissue (P , 0.001) and to a lesser extent in
the skin (P 5 0.001). In contrast, there is no statistically sig-
nificant difference when the joint tissue is compared to the in
TABLE 5. ID50 determination for nonclonal P48 B. burgdorferi strain B31
Inoculum
No. of cultures positive/total no. No. positive mice/
total no. of mice
Calculated ID50
Spleen Joint Heart Bladder Skin All sites Skin Other sites
105 3/3 3/3 3/3 3/3 2/3 14/15 3/3 6.8 3 102 1.6 3 102
104 3/3 3/3 3/3 3/3 2/3 14/15 3/3
103 3/3 3/3 3/3 3/3 3/3 15/15 3/3
102 0/3 0/3 0/3 0/3 0/3 0/15 0/3
101 0/3 0/3 0/3 0/3 0/3 0/15 0/3
TABLE 6. Comparison of genotypic compositions of B. burgdorferi strain B31 P48 clones following either in vitro cultivation
or in vivo selection in C3H/HeN mice
Plasmidd
Presencea in P48
In vitrob (n 5 49)c In vivo
1 2
Skin (OMS)e (n 5 20) Bladder (OMB)e (n 5 20) Joint (OMJ)e (n 5 99) Total (n 5 139)
1 2 1 2 1 2 1 2
cp9 4.1 (2) 95.9 (47) 0 (0)f 100 (20) 0 (0)f 100 (20) 1 (1)i 99 (98) 0.7 (1) 99.3 (138)
lp25 10.2 (5) 89.8 (44) 100 (20)g 0 (0) 100 (20)g 0 (0) 100 (99)g 0 (0) 100 (139) 0 (0)
lp28-1 69.4 (34) 30.6 (15) 85 (17)g 15 (3) 100 (20)g 0 (0) 75.7 (75)i 24.3 (24) 80.6 (112) 19.4 (27)
lp28-4 10.2 (5) 89.8 (44) 0 (0)h 100 (20) 10 (2)h 90 (18) 4 (3)f 96 (96) 3.6 (5) 96.4 (134)
a The values indicate the percentage of samples that contained the given plasmid (1) versus the percentage that lacked the given plasmid (2). Actual numbers of
samples are indicated parenthetically.
b Reflects the eight different genotypic variants shown in Table 3.
c Number of individual colonies (clones) tested.
d Plasmids lost either individually or as a group in the genotypic variants shown in Table 3.
e See Table 1.
f x2 analysis indicates a selection (P , 0.05) against this plasmid when this tissue is compared to the in vitro sample.
g x2 analysis indicates a significant selection (P , 0.001) for this plasmid when this tissue is compared to the in vitro sample.
h x2 analysis indicates a significant selection (P , 0.001) against this plasmid when this tissue is compared to the in vitro sample.
i x2 analysis indicates no significant selection for or against this plasmid when this tissue is compared to the in vitro sample.
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vitro-grown clones (75.7% lp28-11 in the joint relative to
69.4% in vitro). The statistical significance of these data is
shown in Table 6. The overall value calculated for the in vivo
selection of lp28-1 is thus skewed due to the reduced selection
within the joint, with an additional minor effect mediated by
the skin samples. These results demonstrate that B. burgdorferi
variants lacking lp28-1 are able to infect and disseminate to
joint tissue and presumably other organs but are capable of
persisting only within the joint.
DISCUSSION
The hypothesis that B. burgdorferi plasmids carry infection-
associated genes is supported by the fact that prolonged serial
in vitro cultivation of infectious uncloned isolates changes the
plasmid profiles of this organism and results in the loss of
infectivity (21, 22, 30). Our observation that various forms of
B. burgdorferi can be isolated from infected mouse tissues in-
dicates that such heterogeneity is also permissive in vivo (Table
6). These results raise the question as to how B. burgdorferi
become genetically variable at the plasmid level. One possible
explanation involves the asymmetric distribution of plasmid
DNA following replication and partitioning to daughter cells
or, alternatively, it may reflect an in vitro adaptation resulting
in the selection against cells carrying all or most of the plas-
mids. One might predict that partitioning of so many plasmid
DNAs could be a stochastic process; however, we see a distinct
bias toward the loss of the cp9, lp25, lp28-1, or lp28-4 plasmid.
The observation that B. burgdorferi strains show variability in
their plasmid contents in vitro and in vivo indicates that a
significant degree of genomic plasticity for plasmid DNA is
tolerated in this bacterium. However, despite the differences
observed at the DNA level, very few changes in the total
protein profile have been observed previously (21, 22, 30), and
such changes were not observed in our analyses here (data not
shown).
There is a possibility that the phenotype we observe for our
clonal mutants is due to subtle changes within the genomic
DNA, i.e., point mutations or rearrangements. One argument
against this comes from concurrent studies of Purser and Nor-
ris (Abstr. 100th Gen. Meet. Am. Soc. Microbiol.) that indicate
a similar phenotype for the mutants we have reported in this
study. A recent report by Anguita et al. (1) demonstrated that
B. burgdorferi strain N40 passaged 75 times in vitro was inca-
pable of causing carditis and arthritis and gave rise to altered
gene expression but was still infectious in all tissues tested.
None of the plasmids tested were missing from the passage 75
isolate, suggesting that other subtle genomic changes were
responsible for the altered gene expression and the resulting
phenotypes observed; however, the authors evaluated only 6 of
the 21 plasmid species (1). Therefore, it is possible that the
decrease in pathology and gene expression observed was linked
to the absence of one of the 15 plasmids not accounted for in
their analysis. The different phenotypes observed with our mu-
tant clones may be explained by differential gene expression
due to the loss of a regulatory locus that either directly or
indirectly affects an operon or regulon. Studies to address this
hypothesis are in progress.
In contrast to earlier studies with other animal models (30),
our study also evaluated joint tissue from infected animals.
This is particularly important inasmuch as B. burgdorferi infec-
tion can result in arthritic manifestations, particularly late in
infection (25–27). Norris et al. reported that a low-infectivity
clonal isolate of strain Sh-2-82 was capable of colonizing only
the joints and hearts of infected C3H/HeN mice (14); however,
the molecular basis of this defect was not reported at that time.
In light of our results and those of Purser and Norris (Abstr.
100th Gen. Meet. Am. Soc. Microbiol.), this low infectivity
clone was almost certainly missing the lp28-1 linear plasmid, as
this phenotype is evident for both variants MSK10 and ML28
(Table 4). We have also followed up on the ID50 analyses by
determining the genotypic contents of clones obtained from
the infected tissues (Table 6). This assessment was crucial in
order to exclude or confirm the genotypes of the clones we had
identified from our polyclonal P48 isolate. Our results indi-
cated that in instances when a specific plasmid yielded a weakly
reactive product, that plasmid was most likely missing from
clones obtained from the infected tissue(s). This was due to the
inherent sensitivity of PCR (data not shown), which was capa-
ble of detecting plasmid species even if they were present in
only a minority of the cells. For example, the B. burgdorferi
strain B31 variant ML28 was purported to lack only cp9 fol-
lowing PCR, with a weakly reactive lp28-1 signal, implying that
some of the cells were missing lp28-1 even though this isolate
was obtained from an individual colony. Upon infection of this
isolate and subsequent plating of the joint tissue, the genotypic
analysis of the clones obtained indicated that all of the samples
tested (20 clones total) did not contain lp28-1, suggesting ei-
ther that the great majority of the cells used in the infection (at
least greater than 1 in 20) were lp28-12 or that, due to the lack
of selective pressure within the joint, lp28-1 was lost from these
B. burgdorferi cells. Surprisingly, lp28-4 was also missing from
the bulk (65%) of the isolates, implying a similar type of
selection against cells carrying this plasmid. These results in-
dicate that a clonal isolate of B. burgdorferi may be genetically
diverse, and therefore, one must be cautious when attempting
to link the phenotype observed to the genotype of the sample
obtained.
Clearly the lack of selection observed in vitro does not mimic
what is seen in vivo, especially for lp25 and lp28-1. For these
plasmids, there is a selection within the mouse relative to cells
grown in vitro in BSK-II medium. This was particularly evident
in the mouse positive-selection screen, which indicated that
lp25 was present in all 139 clones tested, including samples
taken from skin, bladder, and joint tissues (Table 6). In con-
trast, there was only partial selection evident for either cp9 or
lp28-4, depending on the tissue tested (Table 6). This is in
agreement with a recent study showing that the cp9 plasmid is
not selected for in the Peromyscus mouse yet is in the Ixodes
arthropod vector (19), suggesting that genes on cp9 are more
important for survival and/or transmission in the tick vector
than for colonization and maintenance in the reservoir host.
The data on lp28-1 were somewhat more complicated due to a
reduced selection in the joint (;76% lp28-1 positive) relative
to the skin (85% lp28-1 positive) and bladder (100% lp28-1
positive). The frequency of B. burgdorferi containing lp28-1 in
joint tissue was approximately the same as that observed in
vitro (Table 6). Statistical analysis indicated that no significant
difference occurred in vitro versus within the joint, consistent
with the phenotype observed for MSK10 and ML28. That is,
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since lp28-12 spirochetes were able to colonize the joint more
efficiently than other tissues, it is not surprising that there is an
apparent lack of selection for B. burgdorferi containing this
plasmid. Taken together, one possible interpretation for these
results would be that all of the different plasmid combinations
for the P48 sample (as shown in Table 3) infect and dissemi-
nate throughout the mouse but only those that contain lp25,
and to a lesser extent lp28-1, are able to colonize and persist
for the period tested. The noted exception is in the joint, where
B. burgdorferi, whether it contains lp28-1 or not, is able to
colonize this tissue.
The fact that lp28-12 cells are capable of persisting in joint
tissue suggests that some protein or proteins on lp28-1 are
required for maximal survival at other sites within the host,
e.g., skin, bladder, or lymph nodes. Presumably the antigenic
variant VlsE (32), encoded by lp28-1, is required for mainte-
nance within tissues other than the joint (except when lp25 is
also missing [Table 4]). This result implies that the ability to
evade the host immune response via VlsE-specific antigenic
variation is apparently not required within the joint. One pos-
sibility is that lp28-1 encodes an adhesin essential for coloni-
zation in all tissues excluding the joint. B. burgdorferi is be-
lieved to be an extracellular pathogen, and since only a small
number of spirochetes are presumed to be present within most
infected tissues, their ability to evade host immunity requires
that they migrate to immunoprotected niches. This is particu-
larly important since the infected host mounts a potent hu-
moral response that does not clear B. burgdorferi in vivo yet
elicits killing of B. burgdorferi in vitro. Some protein or proteins
encoded on lp28-1, other than VlsE, may provide B. burgdorferi
with the proper molecular components to survive in all of the
microenvironments in which the spirochete resides except the
joint. Another possibility could be the access or exposure to
interstitial fluid, not found in the joint, which contains com-
plement proteins. It is possible that lp28-1 encodes some pro-
tein or proteins that are required for serum resistance in B.
burgdorferi and that survival within the joint could be tolerated
without lp28-1 in the absence of complement proteins. We are
currently in the process of testing whether the lp28-12 strains
MSK10 and ML28 are serum sensitive relative to wild-type B.
burgdorferi. Alternatively, it may be that survival of lp28-12
cells in the joint is related to the time frame (2 weeks) of our
study. Studies of later time points may indicate that lp28-12 B.
burgdorferi cells are cleared from joint tissue, indicating that
cells lacking lp28-1 are protected from the host immune re-
sponse in joints for longer times than in other tissues.
The positive selection observed for lp25 and lp28-1 implies
that genes present on these plasmids and their requisite pro-
tein products are required for the establishment of infectious
foci in different tissues throughout the mouse. That lp25 and
lp28-1 are required for maximal infectivity is somewhat sur-
prising, as these two plasmids have been categorized as “poorly
behaved,” along with eight other B. burgdorferi plasmids (5).
This is because lp25 and lp28-1 each have only 10 open reading
frames greater than 300 bp in length and have 28 or 39 genes
that are either smaller than 300 bp or appear to be pseudo-
genes, respectively. This lack of genetic information was inter-
preted to imply that these plasmids might be undergoing an
evolutionary process that could ultimately result in their elim-
ination (5). Our results, however, argue that lp25 and lp28-1
are important for B. burgdorferi survival within the mouse. As
such, some of these genes, whether large or small, appear to be
important for wild-type levels of infectivity.
Although lp25 and lp28-1 are the only plasmids missing that
result in a reduced-infectivity phenotype in this study, McDow-
ell et al. (unpublished) demonstrated that other clonal mutants
result in noninfectious variants of B. burgdorferi strain B31.
The differences in these studies are perhaps related to the time
frame of the infection in C3H/HeJ mice, i.e., only 2 weeks for
the study reported here and greater than 3 months in the
related analysis. The results of the long-term study indicate
that some clones obtained from infected mouse skin lacked
lp28-3, along with other plasmids (lp5 and cp9 in most samples
tested), but contained lp25 and lp28-1, yet were noninfectious
upon subsequent intradermal challenge in C3H/HeJ mice (Mc-
Dowell et al., unpublished). These results imply that several
plasmids in the correct combinations may be required to me-
diate mammalian infection. For example, lp25 and some other
plasmid, perhaps lp28-3, may be required together for wild-
type infectivity in B. burgdorferi strain B31. If either lp25 or
lp28-3 is missing, the B. burgdorferi cells are no longer infec-
tious. It is important to note that clones obtained at 3 months
postinfection were capable of persisting within the mouse but
are unable to recolonize and/or disseminate upon reinfection.
It seems unlikely that a selection against plasmids would occur,
inasmuch as the clonal mutants lacking lp28-3 are noninfec-
tious and would have a selective disadvantage for downstream
propagation. Such a negative selection in vivo would ultimately
result in a population of B. burgdorferi that would be dead-end
pathogens, that is, unable to spread to new hosts, and would
thereby be eliminated from the infectious cycle that moves
between arthropods and small rodent species. Therefore, it
seems more likely that the loss of plasmids is a stochastic event
that permits persistent infection and results in a significant
degree of genomic plasticity in vivo over time. One might
envision that some mutant clones might have a short-term
selective advantage in vivo if the plasmid they are missing
encodes a target for humoral immune clearance yet might be
attenuated for downstream infectivity due to the absence of
plasmids required for virulence. Evidence provided by several
investigators indicates that B. burgdorferi has laterally trans-
ferred plasmids, specifically cp26 and lp38, which encode OspC
and OspD, respectively (11, 12). These results suggest that B.
burgdorferi can transfer plasmids; however, the mechanism that
B. burgdorferi uses to exchange DNA is not known at this time.
It is thus tempting to speculate that B. burgdorferi may be
capable of reacquiring previously lost plasmids required for
maximal infectivity. This mechanism, if operative in vivo,
would represent a novel modality for B. burgdorferi to modu-
late its genome and regain virulence.
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ADDENDUM IN PROOF
As a follow-up to the abstract cited in this study, Purser and
Norris have demonstrated a correlation between reduction in
infectivity in C3H/HeN mice and loss of either lp25 or lp28-1
from Borrelia burgdorferi clonal isolates (J. E. Purser and S. J.
Norris, Proc. Natl. Acad. Sci. USA, in press).
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